+1-888-308-5802     
News Contact Us

In-Vitro Colorectal Cancer Screening Tests Market Future Challenges and Industry Growth Outlook by 2020-2025

Author : Ronak Bora | Published Date : 2020-09-17 

In-Vitro Colorectal Cancer Screening Tests Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

The increasing number of technological advancements in cancer screening techniques has led to reliable in-vitro colorectal cancer screening tests. Simultaneously, the rising demand for non-invasive cancer diagnosis solutions has designed a slew of business opportunities for firms operating in this vertical.

As per reports, in-vitro colorectal cancer screening tests market size may cross USD 1.3 billion in total valuation by the end of 2025. The growing geriatric population in both developed and developing nations are vulnerable to colorectal cancer which will support developments in the business growth in the coming times.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/451

Busy work schedules and changes in lifestyles along with the emergence of medical conditions like obesity, type 2 diabetes, and inflammatory bowel disease will intensify the cases of colorectal cancer. With many public and private undertakings introducing effective awareness programs related to the importance of screening tests and the need to ensure early detection of cancer, global in-vitro colorectal cancer screening tests market is sure to witness enormous growth over the next decades.

Some of the leading industry players include Alere, Beckman Coulter, Siemens Healthcare, EMD Millipore, and Abbott Molecular to name a few. Mentioned below are some of the factors expected to influence the market trends in the coming years.

Molecular screening and DNA testing have in particular gained considerable recognition over the years. They have become an important part of routine patient care. Checking at-risk individuals for inherited colorectal cancer, expected to transfer from individual gene testing, which is mainly done to the entire genome or whole exome sequencing. It provides supplementary data of the patient’s genome that may not be directly related to the colorectal cancer syndrome disease.

Increasing advancements in patient management techniques over the years along with the expansion in screening technologies and developments in cancer treatment solutions has majorly supported developments in the industry over time.

In the year 2018, Fecal occult blood tests were responsible for nearly 8.3% of the total revenue share of the market and will continue to showcase considerable gains in the coming years. Easy-to-use and cost-effectiveness are the two main reasons behind developments in the industry over time. FOBT is further segmented into Guaiac FOB Stool, Immuno-Fob ELIS, Immuno-FOB Agglutination, and Lateral Flow Immuno-FOB. 

Immuno-FOB agglutination and test Immuno-FOB ELISA sub-segments have particularly contributed towards the industry expansion. Growing specificity along with the sensitivity of stool-based tests have driven its adoption rate, which is positively influencing in-vitro colorectal cancer screening tests market growth over the years.

The U.S. has emerged as a profitable revenue terrain over the years and has driven the North America in-vitro colorectal cancer screening test industry outlook. Unhealthy dietary habits due to the increase in consumption of processed, packaged food along with high consumption of alcohol have led to an increase in the number of people with chronic diseases in the region. According to the American Cancer Society, the total cases of colorectal cancer in the U.S. by the end of 2020 could be estimated at, 43,340 new cases of rectal cancer and 104,610 new incidences of colon cancer.

The advanced healthcare industry in the region due to the demand for updated healthcare solutions along with the easy availability of healthcare financing has supported advancements in the regional cancer screening market.

The researchers are constantly working towards developing new, enhanced modes of cancer testing to ensure the process is less painful and reliable. For instance, in the year 2019, professors at Maastricht University, Netherlands unveiled their ABC- Cancer Project that aims at offering non-invasive colorectal cancer screening with the help of biomarkers in patient’s breath, instead of fecal blood testing that may carry a high risk of showing false-positive results.

The main aim of the ABC- Cancer project is to develop a screening tool that may be applied easily to people belonging to the high-risk groups and that may be implemented along with the prevailing ongoing test protocols. 

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/in-vitro-colorectal-cancer-screening-tests-market-report

Partial Chapter of the Table of Content 

Chapter 2. Executive Summary

2.1. In-Vitro colorectal cancer screening tests industry 3600 synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Test type trends

2.1.3. Regional trends

Chapter 3. In-Vitro Colorectal Cancer Screening Tests Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Improvements in colorectal cancer screening through non-invasive methods

3.3.1.2. Advancements in the field of diagnosis

3.3.1.3. Rising prevalence of colorectal cancer

3.3.1.4. Cost-efficient and High-speed DNA sequencing

3.3.2. Industry pitfalls & challenges

3.3.2.1. Lack of uniform cancer screening guidelines in Asia Pacific

3.3.2.2. Inadequate reimbursement coverage

3.3.2.3. Shortage of trained staff in developing regions

3.4. Regulatory landscape

3.4.1. U.S.

3.4.2. Europe

3.4.3. China

3.5. Technology landscape

3.6. Growth potential analysis

3.6.1. By test type

3.7. Porter’s analysis

3.8. Competitive landscape, 2017

3.8.1. Strategy dashboard

3.9. PESTEL analysis

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

North America Dental Implants Market Size to Surpass USD 1.78 Billion by 2024

Published Date: 2020-09-25         Author: Ronak Bora

The research report on North America Dental Implants Market offers a thorough understanding on this industry with significant details subject to its overall foothold in the global landscape and its application across major end-user industries and sectors. According to this report, North America dent... Read More

North America Attapulgite Market - A USD 170 million Opportunity by 2024

Published Date: 2020-09-25         Author: Ronak Bora

The study on North America Attapulgite Market provides a complete view on the industry with intricate details subject to its overall stance in the global landscape along with specifying various applications across major end-user sectors. North America attapulgite industry, as per the given report... Read More

North America Biomedical Refrigerators and Freezers Market Size to Exceed USD 1.4 Billion by 2024

Published Date: 2020-09-25         Author: Ronak Bora

The research report on North America Biomedical Refrigerators and Freezers Market provides a comprehensive understanding of the overall market with substantial details including its position in the global economy and its applications across myriad end-users segments. According to the given report... Read More

© 2020 Fractovia. All Rights Reserved